Bharat Biotech has entered into partnership in 2021 to produce part of the malaria vaccine that has been developed by British ...

In a recent development, Bharat Biotech and GSK announced a price reduction of $5, which aims to improve access and save ...

India's biotechnology sector has surged from $35.5 billion in 2014 to $165.7 billion in 2024, aiming for $300 billion by 2030 ...

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world's first malaria vaccine for children 'RTS,S' developed by GSK, PATH and partners, by more than ...

The Danish company has introduced five dosage options for its self-injectable weight-loss drug, with variable monthly pricing ...

Indian pharmaceutical and biotech sectors are witnessing benefits from the global shift away from China. Companies report increasing conversions of enquiries into contracts. While significant ...

Indian pharmaceutical and biotech sectors have started witnessing tangible benefits from the global shift away from China, as early signs of the China 1 strategy materialising emerge, according to a ...

India has proposed increasing US manufacturing by Indian pharma providers of APIs and the final stages of drug processing ...

Hyderabad based vaccine maker Bharat Biotech International Limited (BBIL) has in-licensed a potential vaccine candidate for ...

Novo Nordisk launches Wegovy® in India, a weight management therapy reducing cardiovascular risks for people with obesity.

Ankit Aggarwal is an Executive Director at J.P. Morgan in New York, where he leads capital markets and strategic advisory for healthcare companies. He has advised on multibillion-dollar M&A and ...